文献速递外周动脉疾病

血管内碎石术治疗慢性肢体威胁性缺血患者钙化腘动脉及膝下病变的12个月结局

Twelve-Month Outcomes of Intravascular Lithotripsy for Treatment of Calcified Popliteal and Infrapopliteal Lesions in Patients With Chronic Limb-Threatening Ischemia.
PubMed 文献 · J Endovasc Ther · 2023-10-18

这项前瞻性多中心队列研究在4个中心纳入29例患者30条肢体,评估血管内碎石术治疗腘动脉及膝下钙化病变的12个月结局。30天内发生4例主要不良事件,包括1例闭合装置失败、1例大截肢和2例死亡(均与研究器械无关)。慢性肢体威胁性缺血患者12个月一期通畅率68.8%、免于靶病变血运重建率93.3%、保肢率83.9%、无截肢生存率57.1%。

要点

  • 30天主要不良事件4例:闭合装置失败1例、大截肢1例、死亡2例(与研究器械无关)。
  • 严重钙化占84.4%,补救性支架置入仅12.5%。
  • 慢性肢体威胁性缺血患者12个月一期通畅率68.8%、保肢率83.9%、无截肢生存率57.1%。

核心结论

  • 首次对腘动脉及膝下动脉血管内碎石术随访结局的分析显示,安全性和有效性结果有前景,补救性支架置入率低。

研究设计与样本

  • 前瞻性、多中心队列研究,纳入4个中心所有接受腘动脉及膝下动脉血管内碎石术治疗的患者。
  • 2021年4月至2023年3月间共治疗29例患者30条肢体,共32个病变。
  • 计划在6至8周和12个月进行标准化双功超声随访。

主要发现

  • 糖尿病占62.1%,慢性肢体威胁性缺血占80.0%。
  • 32个病变中严重钙化占84.4%,补救性支架置入占12.5%。
  • 30天内发生4例主要不良事件:1例闭合装置失败、1例大截肢、2例死亡(均与研究器械无关)。
  • 慢性肢体威胁性缺血患者12个月一期通畅率68.8%、一期辅助通畅率90.0%、免于靶病变血运重建率93.3%、保肢率83.9%、无截肢生存率57.1%。
  • 间歇性跛行患者中未发生再狭窄、再闭塞、靶病变血运重建、大截肢或死亡事件。

临床怎么用

  • 作者认为,血管内碎石术在腘动脉及膝下动脉病变中显示出有前景的安全性和有效性结局,补救性支架置入率低。
  • 作者指出,有必要将血管内碎石术与单纯血管成形术或其他血管准备器械在腘动脉及膝下动脉疾病中进行比较。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Vessel calcification is estimated to be present in 30% to 50% of patients with peripheral arterial disease (PAD) and is one of the main challenges in endovascular treatment. The popliteal artery is unique compared with other arteries due to its exposure to significant deformation and biomechanical stress during knee motion. Intravascular lithotripsy (IVL) is a novel technique that uses acoustic pressure waves to cause microfractures within the intimal and medial wall calcification. Intravascular lithotripsy is safe in femoropopliteal and infrapopliteal lesions, but follow-up studies are lacking. Therefore, the purpose of this study was to describe the first follow-up outcomes of IVL in popliteal and infrapopliteal arterial disease. METHODS: This prospective, multicenter cohort study included all patients treated with IVL in the popliteal and infrapopliteal arteries at 4 sites. Standardized follow-up with duplex ultrasonography was scheduled at 6 to 8 weeks and 12 months. The primary safety endpoint was a composite of major adverse events (MAEs) at 30 days. Primary efficacy endpoints were primary patency, limb salvage, and amputation-free survival (AFS) at 12 months. Secondary endpoints were primary-assisted patency and freedom from target lesion revascularization (TLR). Endpoints were distributed for patients with chronic limb-threatening ischemia (CLTI) and intermittent claudication (IC) and estimated using the Kaplan-Meier method. RESULTS: Between April 2021 and March 2023, 29 patients with 30 limbs were treated. Diabetes mellitus (DM) and CLTI were present in 62.1% and 80.0% of patients, respectively. Within the 32 treated lesions, severe calcification was present in 84.4% and bailout stenting was necessary in 12.5% of the lesions. Four MAEs occurred within 30 days: 1 closure device failure, 1 major amputation, and 2 deaths, neither of which was related to the study device. The primary patency, primary-assisted patency, freedom from TLR, limb salvage, and AFS at 12 months were 68.8%, 90.0%, 93.3%, 83.9%, and 57.1% for CLTI patients, respectively. No events occurred in restenosis, re-occlusion, TLR, major amputation, or mortality in patients with IC. CONCLUSIONS: This first-ever analysis on follow-up outcomes of IVL in the popliteal and infrapopliteal arteries demonstrated promising safety and efficacy outcomes with a low rate of bailout stenting.Clinical ImpactVessel calcification is a common feature in peripheral arterial disease (PAD) and is one of the main challenges in endovascular treatment. The popliteal artery is subjected to biomechanical stress during knee motion, which makes stenting unappealing and often leads to worse clinical outcomes. This study aimed to describe the first follow-up outcomes of IVL in popliteal and infrapopliteal arterial disease. As in line with previous studies, no relevant procedural complications were found and the rate of bail-out stenting was only 12.5%. Moreover, in a complex patient population, this study demonstrated promising safety and efficacy outcomes. The comparison of IVL with angioplasty alone or other vessel preparation devices for popliteal and infrapopliteal arterial disease is warranted.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Nugteren MJ, Hazenberg CEVB, Akkersdijk GP, et al. Twelve-Month Outcomes of Intravascular Lithotripsy for Treatment of Calcified Popliteal and Infrapopliteal Lesions in Patients With Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2023. PMID: 37853746. doi:10.1177/15266028231205421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。